The siRNAs targeting PARP-7 were from Dharmacon (see below) and the control siRNA (SIC001) was from Sigma. The siRNA oligos were transfected into OVCAR4 cells at a final concentration of 30 nM using Lipofectamine RNAiMAX reagent (Invitrogen, 13778150) according to the manufacturer’s instructions. The cells were used for various assays 24 hr after siRNA transfection. The siRNA oligos used to knockdown PARP7 mRNA were as follows:
PARP7 siRNA 1: D-013948–08 (our siRNA #1)
PARP7 siRNA 2: D-013948–09 (our siRNA #2)
PARP7 siRNA 4: D-013948–07 (our siRNA #3)
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.